wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26991472-815B16CE-8D78-45F1-AB26-23AF49CB26D2
Q26991472-815B16CE-8D78-45F1-AB26-23AF49CB26D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26991472-815B16CE-8D78-45F1-AB26-23AF49CB26D2
Extracellular Hsp90 (eHsp90) as the actual target in clinical trials: intentionally or unintentionally
P2860
Q26991472-815B16CE-8D78-45F1-AB26-23AF49CB26D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26991472-815B16CE-8D78-45F1-AB26-23AF49CB26D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eade0c5847addd6c955176953e0da2e27443101c
P2860
HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab.